Neves JS - Search Results

1

Mineralocorticoid Receptor Antagonist Combined with SGLT2 Inhibitor versus SGLT2 Inhibitor Alone in Chronic Kidney Disease: A Meta-Analysis of Randomized Trials.

Ferreira JP, Oliveira AC, Vasques-Novoa F, Leite AR, Mendonça L, Zannad F, Butler J, Leite-Moreira A, Saraiva F, Neves JS. Ferreira JP, et al. Among authors: neves js. Am J Nephrol. 2025;56(2):236-242. doi: 10.1159/000541686. Epub 2024 Nov 7. Am J Nephrol. 2025. PMID: 39510041

2

Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure.

Ferreira JP, Sharma A, Butler J, Packer M, Zannad F, Vasques-Nóvoa F, Leite-Moreira A, Neves JS. Ferreira JP, et al. Among authors: neves js. J Clin Endocrinol Metab. 2023 Dec 21;109(1):4-9. doi: 10.1210/clinem/dgad398. J Clin Endocrinol Metab. 2023. PMID: 37409733 Free article. Review.

3

Response to Letter to Editor From Banerjee et al: "Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure".

Ferreira JP, Neves JS. Ferreira JP, et al. Among authors: neves js. J Clin Endocrinol Metab. 2024 Jan 18;109(2):e875. doi: 10.1210/clinem/dgad507. J Clin Endocrinol Metab. 2024. PMID: 37623824 No abstract available.

4

Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed.

Ferreira JP, Neves JS, Saraiva F. Ferreira JP, et al. Among authors: neves js. J Card Fail. 2024 Feb;30(2):418-420. doi: 10.1016/j.cardfail.2023.12.002. Epub 2023 Dec 19. J Card Fail. 2024. PMID: 38128642 No abstract available.

5

Comparison of interleukin-6 and high-sensitivity C-reactive protein for cardiovascular risk assessment: Findings from the MESA study.

Ferreira JP, Vasques-Nóvoa F, Neves JS, Zannad F, Leite-Moreira A. Ferreira JP, et al. Among authors: neves js. Atherosclerosis. 2024 Mar;390:117461. doi: 10.1016/j.atherosclerosis.2024.117461. Epub 2024 Jan 24. Atherosclerosis. 2024. PMID: 38306764

6

Does Semaglutide Reduce Kidney Disease Events on Top of SGLT2 Inhibitors in Patients with CKD and T2D?

Ferreira JP, Mendonça L, Neves JS. Ferreira JP, et al. Among authors: neves js. J Card Fail. 2024 Sep;30(9):1181-1182. doi: 10.1016/j.cardfail.2024.05.006. Epub 2024 Jun 4. J Card Fail. 2024. PMID: 38838981 No abstract available.

7

Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?

Neves JS, Zannad F, Butler J, Packer M, Ferreira JP. Neves JS, et al. J Am Coll Cardiol. 2024 Sep 17;84(12):1119-1122. doi: 10.1016/j.jacc.2024.06.026. Epub 2024 Aug 7. J Am Coll Cardiol. 2024. PMID: 39115523 Free article. No abstract available.

8

Anaemia, erythrocytosis, and empagliflozin in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.

Ferreira JP, Zannad F, Vasques-Nóvoa F, Neves JS, Filippatos G, Pocock SJ, Butler J, Packer M, Anker SD. Ferreira JP, et al. Among authors: neves js. Eur Heart J. 2025 Mar 13;46(11):1074-1077. doi: 10.1093/eurheartj/ehae864. Eur Heart J. 2025. PMID: 39657157 No abstract available.

9

Effects of semaglutide on heart failure outcomes.

Neves JS, Packer M, Ferreira JP. Neves JS, et al. Lancet. 2025 Feb 15;405(10478):542-543. doi: 10.1016/S0140-6736(24)02860-5. Lancet. 2025. PMID: 39955112 No abstract available.

10

Blood pressure response to mineralocorticoid receptor antagonists or aldosterone synthase inhibitors according to baseline renin levels.

Leite AR, Angélico-Gonçalves A, Leite-Moreira A, Neves JS, Ferreira JP. Leite AR, et al. Among authors: neves js. J Hum Hypertens. 2025 Jun;39(6):462-464. doi: 10.1038/s41371-025-01021-9. Epub 2025 May 3. J Hum Hypertens. 2025. PMID: 40319182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters